News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
MannKind Corporation 2Q Loss Narrows on Lower Expenses
August 4, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Biotechnology company MannKind Corp. said late Monday it posted a smaller loss in the second quarter following cuts in research and development spending.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoffs
Pliant Axes 45% of Workforce To Save Cash, Support Late-Stage Clinical Trials
May 2, 2025
·
2 min read
·
Angela Gabriel
Drug pricing
Low-Price Drug Nations Catching ‘Free Ride’ on US Innovation, Report Says
May 2, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
·
2 min read
·
Annalee Armstrong
Earnings
Amgen Advocates For ‘Pro-Growth Tax Policy’ Instead of Tariffs to Boost Domestic Manufacturing
May 2, 2025
·
2 min read
·
Tristan Manalac
